Centiva Capital, LP Regeneron Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 600 shares of REGN stock, worth $426,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares

600

Previous 1,200 50.0%

Holding current value

$426,000

Previous $1.26 Million 50.04%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $371,827 - $450,970	-421 Reduced 86.45%	66 $69,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $415,237 - $456,941	460 Added 1703.7%	487 $468,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.07 Million - $1.22 Million	-1,380 Reduced 98.08%	27 $23,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $974,277 - $1.19 Million	1,407 New	1,407 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $505,417 - $548,735	716 Added 238.67%	1,016 $733,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1.88 Million - $2.37 Million	-3,271 Reduced 91.6%	300 $207,000
Q2 2022 Aug 17, 2022	SELL	$548.35 - $738.84 $7.95 Million - $10.7 Million	-14,500 Reduced 80.24%	3,571 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $8.58 Million - $11.6 Million	15,641 Added 643.66%	18,071 $10.7 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1 Million - $1.17 Million	1,681 Added 224.43%	2,430 $1.7 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $1.23 Million - $1.45 Million	-2,135 Reduced 74.03%	749 $454,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $213,705 - $252,460	452 Added 18.59%	2,884 $1.61 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $1.09 Million - $1.33 Million	2,432 New	2,432 $1.15 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $492,839 - $724,834	-1,466 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $401,874 - $551,963	1,466 New	1,466 $550,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $152,590 - $177,661	-558 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $1.73 Million - $2.4 Million	-5,775 Reduced 91.19%	558 $175,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $1.37 Million - $1.61 Million	3,671 Added 137.9%	6,333 $2.6 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $893,952 - $1.07 Million	2,662 New	2,662 $994,000

Others Institutions Holding REGN

# of Institutions

1,484

Shares Held

83.7M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Regeneron Pharmaceuticals, Inc. Transaction History